导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -30.16% | 1043/1050 |
| 近一周 | -5.04% | 1081/1104 |
| 近一月 | -12.64% | 1092/1103 |
| 近一季 | -20.48% | 982/1092 |
| 近半年 | -36.38% | 1067/1070 |
| 近一年 | -30.00% | 989/1018 |
| 近两年 | 27.67% | 704/926 |
| 近三年 | -22.82% | 785/834 |
| 成立以来 | 202.44% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.35% 579/1070 |
-15.85% 1033/1101 |
- - |
- - |
| 2025 | 35.00% 395/1065 |
3.87% 489/1014 |
-0.11% 696/1038 |
36.11% 263/1050 |
-4.41% 687/1065 |
| 2024 | -14.50% 846/1011 |
-17.20% 932/960 |
-9.40% 843/983 |
19.10% 85/991 |
-4.29% 615/1011 |
| 2023 | -19.19% 654/952 |
6.86% 229/880 |
-8.45% 710/895 |
-14.47% 760/915 |
-3.42% 370/952 |
| 2022 | -32.60% 673/867 |
-23.06% 669/773 |
7.64% 367/806 |
-19.29% 737/845 |
0.83% 397/867 |
| 2021 | 42.93% 30/740 |
-2.91% 264/580 |
25.42% 80/659 |
6.23% 102/704 |
10.50% 74/740 |
| 2020 | 128.65% 6/554 |
-8.18% 361/419 |
51.09% 3/466 |
11.89% 206/517 |
47.29% 5/554 |
| 2019 | 73.88% 22/410 |
29.48% 398/1146 |
-7.67% 897/1228 |
19.93% 15/390 |
21.27% 10/410 |
| 2018 | -27.16% 180/349 |
- - |
-11.95% 594/990 |
1.01% 145/1000 |
-12.68% 683/1080 |
| 2017 | 7.45% 145/285 |
- - |
- - |
- - |
- - |
| 2016 | -5.90% 47/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信智造先锋股票A VS. 东吴新产业精选股票A(580008) |